Editas Medicine Inc’s filing revealed that its CEO O’Neill Gilmore Neil unloaded Company’s shares for reported $66997.0 on Jun 04 ’24. In the deal valued at $5.50 per share,12,191 shares were sold. As a result of this transaction, O’Neill Gilmore Neil now holds 315,279 shares worth roughly $1.6 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mei Baisong sold 511 shares, generating $2,808 in total proceeds. Upon selling the shares at $5.50, the EVP, CHIEF MEDICAL OFFICER now owns 141,032 shares.
Before that, Lucera Erick sold 22,337 shares. Editas Medicine Inc shares valued at $125,404 were divested by the EVP, CHIEF FINANCIAL OFFICER at a price of $5.61 per share. As a result of the transaction, Lucera Erick now holds 116,829 shares, worth roughly $0.59 million.
Morgan Stanley upgraded its Editas Medicine Inc [EDIT] rating to an Equal-weight from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who increased its forecast for the stock in late October from “a Neutral” to “a Buy”. JP Morgan also remained covering EDIT and has increased its forecast on October 18, 2023 with a “Neutral” recommendation from previously “an Underweight” rating. Cantor Fitzgerald revised its rating on October 17, 2023. It rated EDIT as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of EDIT
On Friday, Editas Medicine Inc [NASDAQ:EDIT] saw its stock fall -7.83% to $5.06. Over the last five days, the stock has lost -4.53%. Editas Medicine Inc shares have fallen nearly -50.05% since the year began. Nevertheless, the stocks have fallen -54.37% over the past one year. While a 52-week high of $11.91 was reached on 02/28/24, a 52-week low of $4.91 was recorded on 05/08/24. SMA at 50 days reached $5.66, while 200 days put it at $7.76. A total of 3.33 million shares were traded, compared to the trading of 2.08 million shares in the previous session.
Levels Of Support And Resistance For EDIT Stock
The 24-hour chart illustrates a support level at 4.90, which if violated will result in even more drops to 4.73. On the upside, there is a resistance level at 5.36. A further resistance level may holdings at 5.65. The Relative Strength Index (RSI) on the 14-day chart is 42.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.32%. Stochastics %K at 43.90% indicates the stock is a holding.
